Health Clinical Trial
— NRC250Official title:
The Nutrition Researcher Cohort 2014 Study; New Standardized Self-quantification Methodologies Serving Both Research and Personal Health Maintenance
Verified date | April 2017 |
Source | TNO |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The primary objective of the planned Nutrition Research Cohort (NRC) n250 study is to
develop and evaluate the open access Nutrition Researcher Cohort for gathering personal
health data from nutrition researchers, including analytical methods, standards and
operation procedures, data infrastructure, ethical and privacy aspects, and governance.
Besides, the study aims to exploit and analyse data on food, nutrient and bioactive compound
intake and exposure, biomarkers for food, health and/or disease and health and/or disease
related measurements to study the relation between nutrition, health and development of
disease (on individual level).
In addition, data will be used to develop applications that visualise personal health risks
based for example on (validated) recommendations and applications that predict individual
health risks.
The study is designed as an open, one-group, exploratory cohort study. The total NRC cohort
will be composed of about 250 life sciences employees and students from different,
predominantly European, countries. This allows optimal involvement of participants in
shaping all aspects of the cohort and the ownership of data. We aim to recruit about in
total 20 male and female scientists per participating country.
Status | Active, not recruiting |
Enrollment | 192 |
Est. completion date | January 2025 |
Est. primary completion date | January 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Employees or students that are active in the field of nutrition and/or biology and/or health (e.g. epidemiologists, dieticians, nutrition students and researchers) that have a basic knowledge of nutrition and/or human biology and are thus able to form a scientific judgement on his/her own health data; - good understanding of the English written language, since all communication is handled in English. Exclusion Criteria: |
Country | Name | City | State |
---|---|---|---|
Austria | Medizinische Universität Graz | Graz | |
Belgium | University of Leuven (KU Leuven) | Leuven | |
Czechia | Charles University Prague | Prague | |
Denmark | University of Copenhagen | Copenhagen | |
Finland | University of Eastern Finland | Kuopio | |
France | INRA - L'Institut Nationel de la Recherche Agronomique | Clermont | |
Ireland | University College Dublin | Dublin | |
Italy | CRA-NUT - Centro di Ricerca per gli Alimenti e la Nutrizione | Rome | |
Netherlands | TNO | Zeist | Gelderland |
Spain | University of Barcelona | Barcelona | |
Switzerland | Agroscope, Institute for Food Sciences | Berne | |
United Kingdom | Newcastle University | Newcastle |
Lead Sponsor | Collaborator |
---|---|
TNO | Agroscope Liebefeld-Posieux Research Station ALP, Charles University, Czech Republic, CRA NUT - Centro di Ricerca per gli Alimenti e la Nutrizione, CSIRO Animal, Food and Health Sciences, Humboldt-Universität zu Berlin, Lund University, Newcastle University, NIHS, NuGo, SwissAnalysis AG, Technical University Munchen, Tufts University, Universitaire Ziekenhuizen Leuven, University College Dublin, University of Barcelona, University of Copenhagen, University of Eastern Finland, University of Graz, University of Oslo, VITAS Analytical Services |
Austria, Belgium, Czechia, Denmark, Finland, France, Ireland, Italy, Netherlands, Spain, Switzerland, United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | compliance with the study protocol | compliance will be determined for each of the included measurements and compared between participating countries | after one year (june 2016) | |
Other | user experiences with participating in the cohort | as measured via a questionnaire | after one year (june 2016) | |
Primary | Body height | measured with do-it-yourself device in at-home setting | Baseline (week 1) | |
Primary | Body weight | measured with do-it-yourself device in at-home setting | Each week during entire cohort (five years in total) | |
Primary | Single Nucleotide Polymorphism (SNP) profile | No specific time of measurement has to be specified as genetic profile is not subject to change | Once during the cohort at baseline (a timepoint chosen by the participant in the first three months of the cohort) | |
Primary | Waist-to-hip ratio | measured with waist circumference and hip circumference; measured with centimeter in at-home setting | Monthly during entire cohort (Month 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 for each year of the five year cohort) | |
Primary | Blood pressure | Diastolic and systolic blood pressure; measured with do-it-yourself device in at-home setting | Monthly during entire cohort (Month 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 for each year of the five year cohort) | |
Primary | Resting heart rate | measured after sitting still for at least 5 minutes; measured with do-it-yourself device in at-home setting | Monthly during entire cohort (Month 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 for each year of the five year cohort) | |
Primary | fasting blood glucose | measured after 8h fasting (only drinking water is allowed); measured with do-it-yourself device in at-home setting | Monthly during entire cohort (Month 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 for each year of the five year cohort) | |
Primary | Blood cholesterol | HDL, LDL, total cholesterol, triglycerides; measured with do-it-yourself device in at-home setting | quarterly during entire cohort (Month 3, M6, M9, M12 for each year of the five year cohort) | |
Primary | Food intake | registration of food intake during two weekdays and one weekend day via an online application (e.g. FatSecret) | quarterly during entire cohort (Month 3, M6, M9, M12 for each year of the five year cohort) | |
Primary | Physical activity tracker | Registration of physical activity with a physical activity tracker (e.g. FitBit) for at least one week continuously | quarterly during entire cohort (Month 3, M6, M9, M12 for each year of the five year cohort) | |
Secondary | biomarker profile | biomarkers for food intake (vitamins, fatty acids) and other blood biomarkers (cortisol, C Reactive protein (CRP), thyroid stimulating hormone (TSH), etc.) | once, at baseline (at a timepoint chosen by the participant in the first three months of the cohort); this measure will be repeated only if funding for analysis becomes available | |
Secondary | do-it-yourself oral glucose tolerance test | insulin, glucose, c-peptide, HbA1c; including response profile after oral glucose tolerance test | once, at baseline (at a timepoint chosen by the participant in the first three months of the cohort); this measure will be repeated only if funding for analysis becomes available | |
Secondary | metabolomics | once, at baseline (at a timepoint chosen by the participant in the first three months of the cohort); this measure will be repeated only if funding for analysis becomes available | ||
Secondary | metagenome | once, at baseline (at a timepoint chosen by the participant in the first three months of the cohort); this measure will be repeated only if funding for analysis becomes available | ||
Secondary | general health status | via a questionnaire | once per year during entire cohort (Month 12, M24, M36, M48, M60) | |
Secondary | lifestyle (smoking, alcohol consumption, etc.) | via a questionnaire | once per year during entire cohort (Month 12, M24, M36, M48, M60) | |
Secondary | general food intake | via a food frequency questionnaire | once per year during entire cohort (Month 12, M24, M36, M48, M60) | |
Secondary | quality of sleep | via a questionnaire | once per year during entire cohort (Month 12, M24, M36, M48, M60) | |
Secondary | stress questionnaire | once per year during entire cohort (Month 12, M24, M36, M48, M60) | ||
Secondary | physical activity | via a questionnaire | once per year during entire cohort (Month 12, M24, M36, M48, M60) | |
Secondary | wellness | via a questionnaire | once per year during entire cohort (Month 12, M24, M36, M48, M60) | |
Secondary | cognition | via a questionnaire | once per year during entire cohort (Month 12, M24, M36, M48, M60) | |
Secondary | quality of life | via a questionnaire | once per year during entire cohort (Month 12, M24, M36, M48, M60) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03601715 -
Analysis of Human Tissue Temperature After Application of Therapeutic Modalities.
|
N/A | |
Completed |
NCT02145273 -
Healthy Moms-Healthy Kids: Reducing Maternal Depression for Better Outcomes in Head Start Children
|
N/A | |
Recruiting |
NCT01985152 -
A Phase Ⅰa Study of Azilsartan Trimethylethanolamine in Healthy Volunteers
|
Phase 1 | |
Active, not recruiting |
NCT00970398 -
Effect of an Infant Formula on Infant Growth, Health and Immune Functions
|
N/A | |
Completed |
NCT00332137 -
Effects of Tolterodine, a Non-Specific Muscarinic Antagonist, on Gastrointestinal Transit in Healthy Subjects
|
Phase 2 | |
Recruiting |
NCT06060379 -
Giochiamo 626 - Gaming for Health and Safety in Workplaces
|
N/A | |
Completed |
NCT04998266 -
Evaluation of Physical Capacities Within the Company and Effect of a Personalized Versus Traditional Training Program on the Quality of Life of Sedentary Employees
|
N/A | |
Completed |
NCT01214278 -
Bioavailability of Different n-3 Fatty Acid Formulations
|
Phase 4 | |
Recruiting |
NCT06157346 -
Characteristics of Intestinal Bacteria and Their Effects on Growth and Immune Function in Children at High Altitude
|
||
Completed |
NCT01216605 -
Oxytocin and Emotion Recognition
|
Phase 4 | |
Completed |
NCT01057368 -
The Effects of Well-being Interventions on Affect, Attention, Sleep, Social Stress and Pain Regulation
|
N/A | |
Completed |
NCT02287441 -
Feasibility Study to Increase Vegetable Consumption
|
N/A | |
Completed |
NCT01762553 -
TEA for Families and Children: A Randomized Intervention Trial
|
N/A | |
Completed |
NCT01123772 -
Phase I Dose-Escalation Study to Evaluate Tolerability, Safety & PK of INO-8875 in Healthy Older-Adult Volunteers
|
Phase 1 | |
Completed |
NCT03527654 -
SER Hispano Longitudinal Study
|
||
Recruiting |
NCT02132741 -
Optical Coherence Tomography And NEphropathy: The OCTANE Study
|
||
Completed |
NCT03414346 -
Analysis of the Effects on Human Tissues After Application of Therapeutic Modalities.
|
N/A | |
Completed |
NCT02116283 -
Mobile Sensing of Smoking Behavior
|
N/A | |
Completed |
NCT05104385 -
Hacettepe University COVID-19 Vaccinated's Health Cohort- Students of Health Sciences
|
||
Completed |
NCT00962195 -
The Effect of Purple Sweet Potato (PSP)-Juice on Liver Enzymes and Blood Pressure
|
N/A |